News
Apr 7, 2026
OneBio Secures R20 Million Grant to Propel African Biotech Innovation and Venture Building
News
Startups
Artificial Intelligence
Americas
NewDecoded
3 min read

Image by Andromeda Robotics
Andromeda Robotics has officially launched its flagship humanoid robot, Abi, in the United States to address the growing epidemic of loneliness in aged care. The Australian startup is beginning its American operations with initial deployments in the San Francisco Bay Area. This international expansion follows a successful 23 million dollar Series A funding round that valued the company at 100 million dollars and established a clear path for rapid scaling. Abi is an emotionally intelligent companion standing approximately four feet tall and featuring a colorful, child-like appearance. Unlike industrial robots designed for heavy lifting, Abi is built to provide a sense of presence and warmth for residents in assisted living facilities. CEO Grace Brown conceptualized the robot to ensure that isolated individuals feel seen and heard through genuine interaction and physical presence.
The robot uses a sophisticated AI brain capable of speaking and translating more than 90 different languages. One of its most critical features is a long-term memory system that allows the machine to recall past conversations and personal preferences of residents. To avoid the unsettling nature of many humanoid machines, the team worked with professional animators to ensure Abi's facial expressions and gestures feel approachable and friendly. In practical settings, the robot serves as a dedicated social buffer and an assistant for nursing staff. Abi leads group activities such as music sessions, dancing, and Tai Chi, which helps keep residents engaged and alleviates the workload for human caregivers. The company mission is to replace one billion hours of loneliness with meaningful companionship, focusing on the emotional layer of modern robotics.
As part of the move to California, Andromeda is aggressively recruiting talent from the entertainment sector to further refine the robot’s character and personality. The startup plans to scale its manufacturing capabilities to reach a production target of 100 units per month to meet rising demand. Interested healthcare providers in the United States can now join the official Andromeda Robotics waitlist to begin integrating these humanoid companions into their facilities.
While much of the global robotics industry is locked in a race to automate industrial labor and logistics, Andromeda Robotics has identified a massive social moat in emotional intelligence. By prioritizing presence and character design over complex bipedal walking, the company is bypassing the technical hurdles that plague other humanoid startups. This expansion into the United States signals a shift where social companions are treated as vital medical infrastructure, addressing the global aging crisis by treating loneliness as a treatable condition rather than an inevitability. The move into the Bay Area places the company at the intersection of Silicon Valley technology and California creative talent, solidifying their unique position in the care economy.
Related Articles